药物对比
Linagliptin vs Lixisenatide
Linagliptin 与 Lixisenatide 治疗2型糖尿病：口服DPP-4抑制剂与GLP-1激动剂注射剂。比较A1C、体重、胃肠道副作用和便利性。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when selecting add-on or combination therapy for type 2 diabetes between a DPP-4 inhibitor and a GLP-1 receptor agonist.
结论
Linagliptin offers convenient oral use with a milder side-effect profile, whereas Lixisenatide provides weight-loss potential but requires injection.
全部药物对比